A citation-based method for searching scientific literature

Maíra Teixeira Dória, Jonathan Yugo Maesaka, Raymundo Soares de Azevedo Neto, Nestor de Barros, Edmund Chada Baracat, José Roberto Filassi. Clin Breast Cancer 2018
Times Cited: 15







List of co-cited articles
73 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
236
66

Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision.
Jisun Kim, Wonshik Han, Jong Won Lee, Jee-Man You, Hee-Chul Shin, Soo Kyung Ahn, Hyeong-Gon Moon, Nariya Cho, Woo Kyung Moon, In-Ae Park,[...]. Breast 2012
46
40

A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease.
James W Jakub, Brittany L Murphy, Alexandra B Gonzalez, Amy L Conners, Tara L Henrichsen, Santo Maimone, Michael G Keeney, Sarah A McLaughlin, Barbara A Pockaj, Beiyun Chen,[...]. Ann Surg Oncol 2017
31
33

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Hyung Seok Park, Seho Park, Junghoon Cho, Ji Min Park, Seung Il Kim, Byeong-Woo Park. J Surg Oncol 2013
46
33

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
Sophie Schulz, Peter Sinn, Michael Golatta, Geraldine Rauch, Hans Junkermann, Florian Schuetz, Christof Sohn, Joerg Heil. Breast 2013
40
33

Characteristics associated with upgrading to invasiveness after surgery of a DCIS diagnosed using percutaneous biopsy.
Jean-Charles Hogue, Lucie Morais, Louise Provencher, Christine Desbiens, Brigitte Poirier, Éric Poirier, Simon Jacob, Caroline Diorio. Anticancer Res 2014
17
26

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Amit Goyal, Anthony Douglas-Jones, Ian Monypenny, Helen Sweetland, Guy Stevens, Robert E Mansel. Breast Cancer Res Treat 2006
98
26

Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Larissa C Marques, Gustavo Nader Marta, Juliana Z de Andrade, Danúbia Andrade, Alfredo C S D de Barros, Felipe E M Andrade. Eur J Surg Oncol 2019
10
40

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates.
R J Jackman, F Burbank, S H Parker, W P Evans, M C Lechner, T R Richardson, A A Smid, H B Borofsky, C H Lee, H M Goldstein,[...]. Radiology 2001
253
26

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
199
20

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
207
20

Factors predicting microinvasion in Ductal Carcinoma in situ.
Sibel Ozkan-Gurdal, Neslihan Cabioglu, Beyza Ozcinar, Mahmut Muslumanoglu, Vahit Ozmen, Mustafa Kecer, Ekrem Yavuz, Abdullah Igci. Asian Pac J Cancer Prev 2014
32
20

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
209
20

Is DCIS breast cancer, and how do I treat it?
N Bijker, M Donker, J Wesseling, G J den Heeten, E J Th Rutgers. Curr Treat Options Oncol 2013
31
20


Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
P Meijnen, H S A Oldenburg, C E Loo, O E Nieweg, J L Peterse, E J T Rutgers. Br J Surg 2007
65
20

Features of occult invasion in biopsy-proven DCIS at breast MRI.
Dorota Jakubowski Wisner, E Shelley Hwang, C Belinda Chang, Hilda H Tso, Bonnie N Joe, Juan N Lessing, Ying Lu, Nola M Hylton. Breast J 2013
15
20

Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases.
Chiara Trentin, Valeria Dominelli, Patrick Maisonneuve, Simona Menna, Barbara Bazolli, Alberto Luini, Enrico Cassano. Breast 2012
36
20

Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy.
Nehmat Houssami, Daniela Ambrogetti, M Luke Marinovich, Simonetta Bianchi, Petra Macaskill, Vania Vezzosi, Eleftherios P Mamounas, Stefano Ciatto. Ann Surg Oncol 2011
30
20

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
20

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
B Doyle, M Al-Mudhaffer, M M Kennedy, A O'Doherty, F Flanagan, E W McDermott, M J Kerin, A D Hill, C M Quinn. J Clin Pathol 2009
31
20

A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast.
Takafumi Kondo, Naoki Hayashi, Sachiko Ohde, Koyu Suzuki, Atsushi Yoshida, Hiroshi Yagata, Naoki Niikura, Takayuki Iwamoto, Kumiko Kida, Michiko Murai,[...]. J Surg Oncol 2015
24
20


A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers.
Claudia J C Meurs, Joost van Rosmalen, Marian B E Menke-Pluijmers, Bert P M Ter Braak, Linda de Munck, Sabine Siesling, Pieter J Westenend. Br J Cancer 2018
19
20

Pathologic variables predictive of breast events in patients with ductal carcinoma in situ.
Edwin R Fisher, Stephanie R Land, Reda S Saad, Bernard Fisher, D Lawrence Wickerham, Meihua Wang, Joseph P Costantino, Norman Wolmark. Am J Clin Pathol 2007
49
13

Prognostic classification of breast ductal carcinoma-in-situ.
M J Silverstein, D N Poller, J R Waisman, W J Colburn, A Barth, E D Gierson, B Lewinsky, P Gamagami, D J Slamon. Lancet 1995
506
13

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
457
13

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.
Shi-Yi Wang, Tatyana Shamliyan, Beth A Virnig, Robert Kane. Breast Cancer Res Treat 2011
102
13

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
183
13

Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Ke-Da Yu, La-Mu Wu, Guang-Yu Liu, Jiong Wu, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao. Ann Surg Oncol 2011
50
13

Predictors of microinvasion and its prognostic role in ductal carcinoma in situ.
Gloria R Sue, Donald R Lannin, Brigid Killelea, Anees B Chagpar. Am J Surg 2013
23
13

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes.
Milim Kim, Hyun Jeong Kim, Yul Ri Chung, Eunyoung Kang, Eun-Kyu Kim, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim, In Ah Kim, So Yeon Park. J Breast Cancer 2018
24
13

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
228
13

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Rahul R Parikh, Bruce G Haffty, Donald Lannin, Meena S Moran. Int J Radiat Oncol Biol Phys 2012
52
13

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
N Klauber-DeMore, L K Tan, L Liberman, S Kaptain, J Fey, P Borgen, A Heerdt, L Montgomery, M Paglia, J A Petrek,[...]. Ann Surg Oncol 2000
232
13


Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
A Maffuz, S Barroso-Bravo, I Nájera, G Zarco, I Alvarado-Cabrero, S A Rodríguez-Cuevas. J Exp Clin Cancer Res 2006
34
13

Impact of multifocality and lymph node metastasis on the prognosis and management of microinvasive breast cancer.
Nimmi S Kapoor, Jaime Shamonki, Myung-Shin Sim, Cathie T Chung, Armando E Giuliano. Ann Surg Oncol 2013
32
13



Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
Ellen Warner, Petrina A Causer, John W-N Wong, Frances C Wright, Roberta A Jong, Kimberley A Hill, Sandra J Messner, Martin J Yaffe, Steven A Narod, Donald B Plewes. Breast J 2011
28
13

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
34
13

Ductal Carcinoma In Situ: The Whole Truth.
Ujas Parikh, Chloe M Chhor, Cecilia L Mercado. AJR Am J Roentgenol 2018
19
13

Preoperative Breast Magnetic Resonance Imaging in Women With Local Ductal Carcinoma in Situ to Optimize Surgical Outcomes: Results From the Randomized Phase III Trial IRCIS.
Corinne Balleyguier, Ariane Dunant, Luc Ceugnart, Marguerite Kandel, Marie-Pierre Chauvet, Pascal Chérel, Chafika Mazouni, Philippe Henrot, Philippe Rauch, Jocelyne Chopier,[...]. J Clin Oncol 2019
23
13


Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus.
Y Wahedna, A J Evans, S E Pinder, I O Ellis, R W Blamey, J G Geraghty. Eur J Cancer 2001
27
13

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
55
13

Nonpalpable breast cancer: percutaneous diagnosis with 11- and 8-gauge stereotactic vacuum-assisted biopsy devices.
R F Brem, J M Schoonjans, S N Goodman, A Nolten, F B Askin, O M Gatewood. Radiology 2001
55
13

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.
Kylie L Gorringe, Stephen B Fox. Front Oncol 2017
63
13

Ductal Carcinoma In Situ (DCIS) at Breast MRI: Predictors of Upgrade to Invasive Carcinoma.
Leslie R Lamb, Constance D Lehman, Tawakalitu O Oseni, Manisha Bahl. Acad Radiol 2020
10
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.